Nimustine

DB13069InvestigationalSmall molecule

Nimustine has been used in trials studying the treatment of Glioblastoma.

Mechanism: Pharmacologically active on Glutathione reductase, mitochondrial
Curator reviewed
Formula / weight: C₉H₁₃ClN₆O₂ · 272.69 g/mol (avg)

Resolves to

Compound

Clinical / RWD

Structure

InChIKeyVFEDRRNHLBGPNN-UHFFFAOYSA-NSMILESCC1=NC=C(CNC(=O)N(CCCl)N=O)C(N)=N1

Targets

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

39Drug interactionsStructured to mechanism, not free text

1Clinical trialPhase, status and sponsor resolved per trial

1ATC codeIncluding every combination product, plus 7 drug categories

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Nimustine, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.